SARS-CoV-2 vaccination intentions among mothers of children aged 9 to 12 years: a survey of the All Our Families cohort.

Background: Acceptance of a vaccine against SARS-CoV-2 is critical to achieving high levels of immunization. The objectives of this study were to understand mothers' SARS-CoV-2 vaccine intentions to explore reasons for and against SARS-CoV-2 vaccination.
Methods: Participants from the All Our Families pregnancy longitudinal cohort whose children had reached ages 9-12 years were invited in May-June 2020 to complete a survey on the impact of COVID-19. The survey covered topics about the impact of the pandemic and included 2 specific questions on mothers' intentions to vaccinate their child against SARS-CoV-2. Current responses were linked to previously collected data, including infant vaccine uptake. Multinomial regression models were run to estimate associations between demographic factors, past vaccination status and vaccination intention. Qualitative responses regarding factors affecting decision-making were analyzed thematically.
Results: The response rate was 53.8% (1321/2455). A minority of children of participants had partial or no vaccinations at age 2 ( n = 200, 15.1%). A total of 60.4% of mothers ( n = 798) intended to vaccinate their children with the SARS-CoV-2 vaccine, 8.6% ( n = 113) did not intend to vaccinate and 31.0% ( n = 410) were unsure. Lower education, lower income and incomplete vaccination history were inversely associated with intention to vaccinate. Thematic analysis of qualitative responses showed 10 themes, including safety and efficacy, long-term effects and a rushed process.
Interpretation: Within a cohort with historically high infant vaccination, a third of mothers remained unsure about vaccinating their children against SARS-CoV-2. Given the many uncertainties about future SARS-CoV-2 vaccines, clear communication regarding safety will be critical to ensuring vaccine uptake.
Competing Interests: Competing interests: Suzanne Tough, Sheila McDonald, Erin Hetherington and Sarah Edwards report grants from the Canadian Institutes of Health Research (CIHR) and from Alberta Innovates during the conduct of the study.
(© 2021 CMA Joule Inc. or its licensors.)